The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains with pandemic potential.

One of the many executive actions taken by President Trump on his first official day in office was withdrawing from the World Health Organization.

Washington, D.C., is being thrown into a moment of uncertainty as Biden administration officials begin to depart and make way for the new Trump 2.0 administration. As of Monday, FDA commissioner Robert Califf,

Houston Park and John Knox, trained firefighters, are also in line for roles helping oversee the nation’s emergency preparedness and response.

Secretary Xavier Becerra spoke to The Washington Post about falling trust in his department since the coronavirus pandemic.

The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to

HHS formally debarred EcoHealth Alliance Inc. and its former president Dr. Peter Daszak for allegedly failing to report dangerous gain-of-function research in China.

President-elect Donald Trump's transition team reportedly tapped a former senior health official from the president-elect's first term and a friend to top Trump loyalists to be Robert F. Kennedy Jr's chief of staff.

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready before bird flu strains currently circulating in the wild and on farms can potentially cause human outbreaks.

The US Department of Health and Human Services (HHS) on January 6, 2025 issued a notice of proposed rulemaking (NPRM) seeking feedback on

The harmful effects of private equity in the healthcare delivery system "deserves ongoing scrutiny and greater research," HHS said in a Jan. 15 report .